CHE Chemed Corp

  1. Stocks
  2. Healthcare
  3. NYSE: CHE

Price (delayed)

$466.63

Market cap

$7.44B

P/E Ratio

22.64

Dividend/share

$1.36

EPS

$20.61

Enterprise value

$7.37B

Highlights
Chemed's quick ratio has soared by 65% YoY and by 12% from the previous quarter
The debt has dropped by 52% year-on-year
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.chemed.com/
Peers: AMED LHCG SXT BCPC

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
15.95M
Market cap
$7.44B
Enterprise value
$7.37B
Valuations
Price to earnings (P/E)
22.64
Price to book (P/B)
8.05
Price to sales (P/S)
3.57
EV/EBIT
17.87
EV/EBITDA
15.7
EV/Sales
3.52
Earnings
Revenue
$2.09B
EBIT
$412.49M
EBITDA
$469.43M
Free cash flow
$450.05M
Per share
EPS
$20.61
Free cash flow per share
$28.11
Book value per share
$57.94
Revenue per share
$130.61
TBVPS
$47.72
Balance sheet
Total assets
$1.46B
Total liabilities
$529.25M
Debt
$136.71M
Equity
$928.88M
Working capital
$56.76M
Liquidity
Debt to equity
0.15
Current ratio
1.2
Quick ratio
1.09
Net debt/EBITDA
-0.16
Margins
EBITDA margin
22.4%
Gross margin
34.6%
Net margin
15.7%
Operating margin
18.7%
Efficiency
Return on assets
23.7%
Return on equity
38.9%
Return on invested capital
105.6%
Return on capital employed
35.3%
Return on sales
19.7%
Dividend
Dividend yield
0.29%
DPS
$1.36
Payout ratio
6.6%

CHE stock price

How has the Chemed stock price performed over time
Intraday
-0.94%
1 week
-3.28%
1 month
-3.35%
1 year
3.55%
YTD
-12.39%
QTD
1.48%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.09B
Gross profit
$724.22M
Operating income
$390.76M
Net income
$328.98M
Gross margin
34.6%
Net margin
15.7%
The net income has grown by 42% year-on-year and by 3% since the previous quarter
Chemed's operating income has increased by 36% YoY
The net margin is up by 35% year-on-year
The operating margin has increased by 30% YoY

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
22.64
P/B
8.05
P/S
3.57
EV/EBIT
17.87
EV/EBITDA
15.7
EV/Sales
3.52
The EPS has increased by 43% YoY and by 2.9% from the previous quarter
The price to earnings (P/E) is 23% lower than the 5-year quarterly average of 29.5 and 13% lower than the last 4 quarters average of 26.2
Chemed's equity has increased by 36% YoY and by 3.1% from the previous quarter
The P/B is 11% less than the last 4 quarters average of 9.1
CHE's P/S is 29% above its 5-year quarterly average of 2.8 but 2.4% below its last 4 quarters average of 3.7
The revenue rose by 5% year-on-year

Efficiency

How efficient is Chemed business performance
The company's return on invested capital has surged by 86% YoY and by 16% QoQ
The ROS has increased by 38% YoY and by 2.6% from the previous quarter
The ROA rose by 25% year-on-year
The ROE has grown by 14% YoY but it has contracted by 4.4% from the previous quarter

Dividends

What is CHE's dividend history
DPS
$1.36
Dividend yield
0.29%
Payout ratio
6.6%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 176% higher than its total liabilities
Chemed's quick ratio has soared by 65% YoY and by 12% from the previous quarter
CHE's current ratio is up by 48% YoY and by 9% from the previous quarter
The debt is 85% smaller than the equity
CHE's debt to equity has dropped by 64% year-on-year
The debt has dropped by 52% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.